U 66985
U 66985 is a platelet-activating factor (PAF) receptor antagonist. U 66985 binds to the PAF receptor site, thereby inhibiting PAF-induced platelet aggregation. U 66985 can be used in studies on the PAF signaling pathway and the functions of lipid inflammatory mediators[1][2].
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 99103-16-9
- 分子式: C32H66NO7P
- 分子量:607.85
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
U 66985 (radioimmunoassay; incubation at room temperature overnight) inhibits the binding of [125I]PAF to anti-PAF antibody from rabbit A, with a 50% inhibitory amount of 19 pmol/tube[1]
U 66985 (1 μM; HAG 10 μg/mL; pre-perfused for 5 min prior to HAG stimulation; isolated perfused liver of Sprague-Dawley rats) does not reduce the HAG-induced glycogenolysis response; the maximum increase in glucose release upon U 66985 treatment is 81 μmol/h/g, compared with 80 μmol/h/g in the parallel control group[2].
U 66985 (1 μM; isolated perfused Sprague-Dawley rat liver; pretreated starting at 35 min of perfusion, followed by perfusion with 1 nM [3H]18:0-sn-3-AGEPC during 40-42 min) does not significantly alter the silver grain distribution of [3H]AGEPC in liver tissues; in this experiment, U 66985 is present at a 1000-fold excess relative to the radioligand[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 99103-16-9
-
分子量 607.85
-
分子式 C32H66NO7P
-
SMILES
[C@H](COP(OCCCCCC[N+](C)(C)C)(=O)[O-])(COCCCCCCCCCCCCCCCCCC)OC(C)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
- U 66985
- 99103-16-9
- U66985
- U-66985
- Platelet-activating Factor Receptor (PAFR)
- perfused rat livers
- heat-aggregated immunoglobulin G
- platelet-activating factor receptor
- rabbit A anti-PAF antiserum
- glycogenolytic responses
- sn-3-AGEPC
- glucose release
- rabbit anti-PAF antibodies
- radioimmunoassay
- platelet aggregation
- Inhibitor
- inhibitor
- inhibit